177 related articles for article (PubMed ID: 8578607)
1. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
Whitfield JF; Morley P
Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
[TBL] [Abstract][Full Text] [Related]
3. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
Greenfield EM; Shaw SM; Gornik SA; Banks MA
J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
[TBL] [Abstract][Full Text] [Related]
4. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Delmas PD; Vergnaud P; Arlot ME; Pastoureau P; Meunier PJ; Nilssen MH
Bone; 1995 Jun; 16(6):603-10. PubMed ID: 7669436
[TBL] [Abstract][Full Text] [Related]
5. Recombinant parathyroid hormone in the management of osteoporosis.
Compston J
Calcif Tissue Int; 2005 Aug; 77(2):65-71. PubMed ID: 16059774
[No Abstract] [Full Text] [Related]
6. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.
Henriksen K; Andersen JR; Riis BJ; Mehta N; Tavakkol R; Alexandersen P; Byrjalsen I; Valter I; Nedergaard BS; Teglbjaerg CS; Stern W; Sturmer A; Mitta S; Nino AJ; Fitzpatrick LA; Christiansen C; Karsdal MA
Bone; 2013 Mar; 53(1):160-6. PubMed ID: 23234813
[TBL] [Abstract][Full Text] [Related]
7. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
8. Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1-34).
Whitfield JF; Morley P; Ross V; Isaacs RJ; Rixon RH
Calcif Tissue Int; 1995 Mar; 56(3):227-31. PubMed ID: 7750029
[TBL] [Abstract][Full Text] [Related]
9. Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.
Debiais F
Joint Bone Spine; 2003 Dec; 70(6):465-70. PubMed ID: 14667554
[TBL] [Abstract][Full Text] [Related]
10. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
11. PTH: a future role in the management of osteoporosis?
Reeve J
J Bone Miner Res; 1996 Apr; 11(4):440-5. PubMed ID: 8992874
[No Abstract] [Full Text] [Related]
12. Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women.
Tang Y; Xia H; Kang L; Sun Q; Su Z; Hao C; Xue Y
Med Sci Monit; 2019 Jan; 25():259-268. PubMed ID: 30620727
[TBL] [Abstract][Full Text] [Related]
13. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
14. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
Ito M
Clin Calcium; 2007 Dec; 17(12):1858-64. PubMed ID: 18057661
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the abilities of human parathyroid hormone(1-31)NH2 and human parathyroid hormone-related protein(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
Whitfield JF; Morley P; Willick GE; Ross V; Langille R; MacLean S; Barbier J; Isaacs RJ; Ohannessian-Barry L
Calcif Tissue Int; 1997 Oct; 61(4):322-6. PubMed ID: 9312203
[TBL] [Abstract][Full Text] [Related]
16. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated according to the ADFR (activation, depression of resorption, formation, repeat the cycle) with parathyroid hormone and diphosphonates (Hannover PTH I study)].
Delling G; Dreyer T; Hahn M; Vogel M; Rittinghaus EF; Hesch RD
Z Orthop Ihre Grenzgeb; 1990; 128(1):1-5. PubMed ID: 2138378
[TBL] [Abstract][Full Text] [Related]
17. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.
Sone T; Fukunaga M; Ono S; Nishiyama T
Miner Electrolyte Metab; 1995; 21(1-3):232-5. PubMed ID: 7565456
[TBL] [Abstract][Full Text] [Related]
18. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the ability of recombinant human parathyroid hormone, rhPTH-(1-84), and hPTH-(1-31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats.
Whitfield JF; Morley P; Willick GE; Ross V; MacLean S; Barbier JR; Isaacs RJ; Ohannessian-Barry L
Calcif Tissue Int; 1997 Jan; 60(1):26-9. PubMed ID: 9030476
[TBL] [Abstract][Full Text] [Related]
20. Cyclization by a specific lactam increases the ability of human parathyroid hormone (hPTH)-(1-31)NH2 to stimulate bone growth in ovariectomized rats.
Whitfield JF; Morley P; Willick G; Langille R; Ross V; MacLean S; Barbier JR
J Bone Miner Res; 1997 Aug; 12(8):1246-52. PubMed ID: 9258755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
